Karen Lounsbury, Ph.D., pharmacology professor of and researcher
"Considering the ongoing impact of the opioid epidemic and cannabis' potential as both a major industry and a safer, often far cheaper treatment for various medical conditions, Lounsbery's small risk in bringing cannabis science to academia seems like the right kind to take: Thoughtful, constructive, and evidence-based." - Janet Burns, Forbes
In a July 21, 2018 Forbes
article about UVM's medicinal marijuana course "Cannabis Past, Present, and Future," UVM Professor of Pharmacology and co-designer of the class, Karen Lounsbury, Ph.D., spoke about the structure of the course, the red tape involved in researching cannabis materials, and cannabis as a potential replacement pain-killer for opioid patients.
Read the full article at Forbes.com.